Debt-to-equity of LIGAND PHARMACEUTICALS INC from 31 Mar 2013 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
LIGAND PHARMACEUTICALS INC quarterly Debt-to-equity in % history and change rate from 31 Mar 2013 to 31 Dec 2025.
  • LIGAND PHARMACEUTICALS INC Debt-to-equity for the quarter ending 31 Dec 2025 was 36%, a 178% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

LIGAND PHARMACEUTICALS INC Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 36% +23% +178% 31 Dec 2025
Q3 2025 26% +13% +100% 30 Sep 2025
Q2 2025 14% +0.72% +5.5% 30 Jun 2025
Q1 2025 13% -0.53% -3.8% 31 Mar 2025
Q4 2024 13% -3.6% -22% 31 Dec 2024
Q3 2024 13% -7.6% -37% 30 Sep 2024
Q2 2024 13% -11% -46% 30 Jun 2024
Q1 2024 14% -16% -53% 31 Mar 2024
Q4 2023 17% -16% -49% 31 Dec 2023
Q3 2023 20% -20% -49% 30 Sep 2023
Q2 2023 24% -23% -49% 30 Jun 2023
Q1 2023 29% -24% -45% 31 Mar 2023
Q4 2022 33% -29% -47% 31 Dec 2022
Q3 2022 40% -30% -43% 30 Sep 2022
Q2 2022 47% -28% -38% 30 Jun 2022
Q1 2022 54% -27% -34% 31 Mar 2022
Q4 2021 62% -20% -25% 31 Dec 2021
Q3 2021 70% -13% -16% 30 Sep 2021
Q2 2021 76% -8.4% -10% 30 Jun 2021
Q1 2021 81% -0.83% -1% 31 Mar 2021
Q4 2020 82% +1.5% +1.9% 31 Dec 2020
Q3 2020 83% -1.4% -1.7% 30 Sep 2020
Q2 2020 84% -26% -23% 30 Jun 2020
Q1 2020 82% -60% -42% 31 Mar 2020
Q4 2019 81% -72% -47% 31 Dec 2019
Q3 2019 85% -59% -41% 30 Sep 2019
Q2 2019 109% +5.1% +4.9% 30 Jun 2019
Q1 2019 141% +83% +141% 31 Mar 2019
Q4 2018 153% +92% +150% 31 Dec 2018
Q3 2018 143% +81% +131% 30 Sep 2018
Q2 2018 104% +40% +62% 30 Jun 2018
Q1 2018 59% -7.8% -12% 31 Mar 2018
Q4 2017 61% -5% -7.6% 31 Dec 2017
Q3 2017 62% -9.2% -13% 30 Sep 2017
Q2 2017 64% -11% -15% 30 Jun 2017
Q1 2017 66% -31% -32% 31 Mar 2017
Q4 2016 66% -86% -56% 31 Dec 2016
Q3 2016 71% -163% -70% 30 Sep 2016
Q2 2016 75% -456% -86% 30 Jun 2016
Q1 2016 97% -332% -77% 31 Mar 2016
Q4 2015 152% -119% -44% 31 Dec 2015
Q3 2015 234% +72% +44% 30 Sep 2015
Q2 2015 532% +447% +528% 30 Jun 2015
Q1 2015 430% +323% +301% 31 Mar 2015
Q4 2014 270% +124% +85% 31 Dec 2014
Q3 2014 162% -24% -13% 30 Sep 2014
Q2 2014 85% -155% -65% 30 Jun 2014
Q1 2014 107% -214% -67% 31 Mar 2014
Q4 2013 146% 31 Dec 2013
Q3 2013 186% 30 Sep 2013
Q2 2013 240% 30 Jun 2013
Q1 2013 321% 31 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.